Table 11.
Diagnostic Confidence Scores of 2 Readers at Both Field Strengths for TLE for All Patients (A) and Per Patient (B); Diagnostic Confidence Scores of 2 Readers at Both Field Strengths for Tumor for All Patients (C) and Per Patient (D)
| A | 3 T |
7 T |
||
|---|---|---|---|---|
| Reader 1 | Reader 2 | Reader 1 | Reader 2 | |
| MTS/SU | 0.3 | 3.0 | 4.1 | 4.1 |
| MCD | 1.4 | 1.9 | 5.0 | 3.8 |
| VMMB | 4.0 | 7.8 | 9.0 | 9.0 |
| TLE | 5.6 | 12.6 | 18.1 | 16.9 |
| B |
3T |
7T |
||
| Reader 1 | Reader 2 | Reader 1 | Reader 2 | |
| MTS/SU | 0.0 | 0.4 | 0.5 | 0.5 |
| MCD | 0.2 | 0.2 | 0.6 | 0.4 |
| VMMB | 0.4 | 1.0 | 0.9 | 1.0 |
| TLE | 0.2 | 0.5 | 0.7 | 0.6 |
| C |
3T |
7T |
||
| Reader 1 | Reader 2 | Reader 1 | Reader 2 | |
| EA/IA | 7.3 | 9.8 | 9.8 | 11 |
| S/M | 7.0 | 8.5 | 7.3 | 8.5 |
| B/M | 1.5 | 3.3 | 3.5 | 3.3 |
| Tumor | 15.8 | 21.5 | 20.5 | 22.8 |
| D |
3T |
7T |
||
| Reader 1 | Reader 2 | Reader 1 | Reader 2 | |
| EA/IA | 0.7 | 0.9 | 0.9 | 1.0 |
| S/M | 0.6 | 0.8 | 0.7 | 0.8 |
| B/M | 0.1 | 0.3 | 0.3 | 0.3 |
| Tumor | 0.5 | 0.7 | 0.6 | 0.7 |
MCD indicates malformation of cortical development; MTS/SU, mesial temporal screlosis/subunits; VMMB, vascular malformations or microbleeds; TLE, temporal lobe epilepsy; EA/IA, extra-axial versus intra-axial location; S/M, solitary versus multiple; B/M, benign versus malignant.